Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Controlled Trial Investigating the Use of Genetic Predisposition to Guide Pharmacologic Therapy for Hypertension

NCT02988245 is registered in ClinicalTrials.gov with Geneticure, LLC as lead sponsor.

NCT NCT02988245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02988245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Controlled Trial Investigating the Use of Genetic Predisposition to Guide Pharmacologic Therapy for Hypertension
Lead sponsor
Geneticure, LLC
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2022
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension